The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.
Zuccollo A, Shi C, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, Zang M, Xu S, Jiang B, Oliver-Krasinski JM, Cayatte AJ, Corda S, Lavielle G, Verbeuren TJ, Cohen RA.
Circulation. 2005 Nov 8;112(19):3001-8. Epub 2005 Oct 31.PMID: 16260636 [PubMed - indexed for MEDLINE]Related articlesFree article